NantHealth, Inc. (NASDAQ:NH) is now up 12.31% compared to a 12-month low of $2.60. We have seen the price to move -4.26% lower and get settled at $2.92 on 12/14/2017. At recent session, it appeared stuck in a range of $2.91 to $3.18. This company shares are 105.48% off its target price of $6 and the current market capitalization stands at $317.35M. The recent change has given its price a -18.28% deficit over SMA 50 and -75.56% deficit over its 52-week high. The stock witnessed -13.1% declines, -36.93% declines and -18.21% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found NH’s volatility during a week at 6.22% and during a month it has been found around 7.03%.NantHealth, Inc. (NH) Top Holders
Institutional investors currently hold around $23 million or 23.8% in NH stock. Look at its top three institutional owners. Blackrock Inc. owns $8.13 million in NantHealth, Inc., which represents roughly 2.56% of the company’s market cap and approximately 35.35% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 1,109,824 shares of the stock are valued at $3.39 million. The third largest holder is Blackstone Group L.P., which currently holds $1.82 million worth of this stock and that ownership represents nearly 0.57% of its market capitalization.
At the end of 09/30/2017 reporting period, 26 institutional holders increased their position in NantHealth, Inc. (NASDAQ:NH) by some 1,430,813 shares, 16 decreased positions by 1,038,988 and 11 held positions by 5,219,699. That puts total institutional holdings at 7,689,500 shares, according to SEC filings. The stock grabbed 6 new institutional investments totaling 164,379 shares while 6 institutional investors sold out their entire positions totaling 725,085 shares.NantHealth, Inc. (NASDAQ:NH) Insider Trades
Multiple company employees have indulged in significant insider trading. NantHealth, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that COO Louks Ronald Allen has sold 5,245 shares of NantHealth, Inc. (NH) in trading session dated Dec. 06, 2017. These shares are worth $15,892 and were traded at $3.03 each. The SEC filing shows that Louks Ronald Allen performed a sale of 6,705 shares. The COO disposed these shares by way of transaction on Nov. 06, 2017. The company’s shares were given away at $3.39 per share worth to an income of some $22,730 on account of Louks Ronald Allen.
COO, Louks Ronald Allen, sold 26,820 common shares of NantHealth, Inc. (NH) in the open market. In a transaction dated Oct. 06, 2017, the shares were put up for sale at an average price of $4.28, raking in a sum of $114,790. After this sale, common shares of NH are directly owned by the insider, with total stake valued at $.
In the transaction dated Jun. 07, 2016, the great number of shares acquired came courtesy the CEO, 10% Owner; Soon-Shiong Patrick added a total of 357,143 shares at an average price of $14, amounting to approximately $5,000,002. The insider now directly owns 70,113,411 shares worth $204,731,160.NantHealth, Inc. (NH) Analyst Guide
Several analysts have released their opinion on NantHealth, Inc. (NASDAQ:NH), with 3 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.